What is the current DNA and RNA Synthesizer market size?

The DNA and RNA Synthesizer market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driving future outlook.

What are the key drivers of the DNA and RNA Synthesizer market?

Advances in genetic engineering and rising demand for synthetic biology drive market growth.

What challenges does the DNA and RNA Synthesizer market face?

High development costs and regulatory hurdles are significant challenges for market players.

Which regions are leading the DNA and RNA Synthesizer market?

North America and Europe are currently leading the market due to strong research infrastructure.

Who are the top companies in the DNA and RNA Synthesizer market?

Leading companies include Thermo Fisher, Agilent, and Danaher, driving innovation and growth.

What future opportunities exist in the DNA and RNA Synthesizer market?

Emerging applications in gene editing and vaccine development offer significant future opportunities.

How does technology impact the DNA and RNA Synthesizer market?

Advances in automation and artificial intelligence enhance synthesizer efficiency and accuracy.

What is the current regulatory landscape for DNA and RNA Synthesizers?

Regulatory frameworks vary by region, with ongoing updates to address safety and ethics concerns.

DNA and RNA Synthesizer Growth Analysis & Future Outlook 2033

DNA and RNA Synthesizer by Application (Academic Institution, Pharmaceutical Company, Others), by Types (Laboratory Grade, Industrial Grade, Large-scale Synthesis Grade), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 136

Forecast Period: 2026 - 2033

Market Size: $510 million

CAGR: 12.1%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 136

Forecast Period: 2026 - 2033

Market Size: $510 million

CAGR: 12.1%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

DNA and RNA Synthesizer Market Overview

The DNA and RNA Synthesizer market refers to the industry that provides solutions for the synthesis of DNA and RNA molecules, which are crucial in various fields such as genetic engineering, biotechnology, and pharmaceuticals. As the global demand for genetic research and development continues to rise, the DNA and RNA Synthesizer market size is estimated to be around $1.4 billion in 2025. The growth outlook for this market is promising, with a market forecast that indicates a compound annual growth rate (CAGR) of 13.1% during the forecast period from 2026 to 2033, driven by factors such as advancements in technology, increasing demand for synthetic biology, and rising investments in research and development. The industry expansion is expected to be driven by the growing need for DNA and RNA synthesis in various applications, including gene therapy, vaccine development, and diagnostics.

Loading chart…

The key forces shaping the DNA and RNA Synthesizer industry include technology shifts, such as the development of new synthesis methods and the integration of artificial intelligence and machine learning, regulations, such as those related to genetic engineering and biotechnology, and consumer behavior, such as the increasing demand for personalized medicine. The largest region in the DNA and RNA Synthesizer market is North America, while the fastest-growing region is Asia-Pacific, driven by the growing demand for genetic research and development in countries such as China and India. Overall, the DNA and RNA Synthesizer market is expected to experience significant growth in the coming years, driven by the increasing demand for genetic research and development, and the development of new technologies and applications.

Report Overview

Report Attribute	Details
Market size value in 2025	510.00 million
Revenue forecast in 2033	889.46 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Fisher Scientific; Applied Biosystems; Beckman Coulter; GenScript Biotech; BioAutomation Corporation; K&A Labs GmbH; Protein Technologies; CSBio; ACTGene; Precision System Science; General Electric; Polygen GmbH; GlobalSpec; Biolytic Lab Performance; Tekna Plasma Systems
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The DNA and RNA Synthesizer market is poised for significant growth, driven by various factors. The market dynamics are shaped by several key elements, including growth drivers, restraints, opportunities, and challenges.

Growth Drivers2 items

Advances in gene synthesis technology and the increasing adoption of DNA and RNA synthesizers in research and development activities are driving the growth of the DNA and RNA Synthesizer market size

The growing demand for synthetic biology and the expanding applications of DNA and RNA synthesizers in fields such as genomics and gene editing are also contributing to the market's growth forecast

Restraints2 items

The high cost of DNA and RNA synthesizers and the limited availability of skilled professionals to operate these systems are restraining the growth of the DNA and RNA Synthesizer market

The stringent regulatory requirements and the need for compliance with various laws and regulations are also limiting the adoption of DNA and RNA synthesizers, thereby affecting the market size

Opportunities2 items

The increasing investments in research and development activities and the growing focus on personalized medicine are creating new opportunities for the growth of the DNA and RNA Synthesizer market

The expanding applications of DNA and RNA synthesizers in emerging markets and the growing demand for point-of-care diagnostics are also expected to drive the market's growth forecast

Challenges2 items

The complexity of DNA and RNA synthesis and the need for high-quality reagents and consumables are significant challenges faced by the DNA and RNA Synthesizer market

The intense competition among market players and the need for continuous innovation and product development are also major challenges that are affecting the market size and growth forecast

Market Segmentation

Loading chart…

The DNA and RNA Synthesizer market can be segmented based on Application, which includes research and development, diagnostics, forensic analysis, and other applications. The research and development segment holds a significant share of the market, driven by the increasing demand for DNA and RNA synthesizers in genomics and synthetic biology research. Understanding the DNA and RNA Synthesizer segmentation is crucial for industry players to identify opportunities and trends in the market.

The Types of DNA and RNA synthesizers include [object Object],[object Object], which comprise benchtop synthesizers, automated synthesizers, and manual synthesizers. Benchtop synthesizers are widely used in research laboratories due to their compact design and ease of use. Automated synthesizers, on the other hand, offer high-throughput synthesis capabilities and are commonly used in large-scale research and production environments. The types of DNA and RNA synthesizers play a significant role in determining the overall market size and growth.

DNA and RNA Synthesizer Segmentation Breakdown8 items

Application

Academic Institution

Pharmaceutical Company

Others

Types

Laboratory Grade

Industrial Grade

Large-scale Synthesis Grade

Regional Insights

Loading chart…

The DNA and RNA Synthesizer market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the market share. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of genomics and gene editing technologies, favorable policies, and significant investments in research and development.

Key drivers for North America include a mature ecosystem, high infrastructure development, and a large customer base. Europe is driven by a strong demographics base, with a high demand for DNA and RNA synthesizers in research institutions and pharmaceutical companies. Asia Pacific is driven by investments in emerging economies, a large and growing demographics base, and increasing adoption of advanced technologies.

Latin America and Middle East & Africa are expected to experience steady DNA and RNA Synthesizer market growth, driven by increasing adoption of genomics technologies, improving infrastructure, and growing demographics. However, these regions are expected to account for a relatively smaller share of the market, with Latin America accounting for around 10% and Middle East & Africa accounting for around 5%.

Competitive Landscape

The DNA and RNA Synthesizer market exhibits a moderately consolidated structure, with global players competing alongside local and regional companies. The DNA and RNA Synthesizer competitive landscape is driven by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and strategic partnerships to maintain their market position, while local companies rely on regional expansion and cost advantages to compete.

Companies in this market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and supply chain risks. To overcome these challenges, companies focus on technology, service model, channel strength, customization, and cost advantages to differentiate themselves. Some of the key companies' strategies are outlined below:

Thermo Fisher Scientific: regional expansion

Applied Biosystems: innovation pipeline

Beckman Coulter: premium pricing

GenScript Biotech: local manufacturing

BioAutomation Corporation: OEM tie-ups

K&A Labs GmbH: vertical integration

Key DNA and RNA Synthesizer Companies15 items

Thermo Fisher Scientific

Applied Biosystems

Beckman Coulter

GenScript Biotech

BioAutomation Corporation

K&A Labs GmbH

Protein Technologies

CSBio

ACTGene

Precision System Science

General Electric

Polygen GmbH

GlobalSpec

Biolytic Lab Performance

Tekna Plasma Systems

Market Ecosystem

The DNA and RNA Synthesizer ecosystem encompasses a complex network of participants, spanning upstream technology providers to downstream end users. This ecosystem can be broadly segmented into three stages: upstream, where raw materials and components are sourced; midstream, where integrators and manufacturers produce synthesizers; and downstream, where channels and end users interact. Value is created and captured as technology providers develop innovative solutions, which are then integrated and distributed to meet the demands of end users.

Raw material suppliers — provide essential components

Technology providers — develop synthesis technologies

OEMs/manufacturers — produce DNA and RNA synthesizers

System integrators — configure and install synthesizer systems

Distributors/channel partners — supply synthesizers to end users

Service providers — offer maintenance and support services

End users/buyers — utilize synthesizers for research and applications

In the DNA and RNA Synthesizer ecosystem, control points are primarily held by technology providers and end users, as they influence adoption through innovation and demand, respectively. Dependency risks arise from input constraints, such as the availability of raw materials, and standards approvals, which can impact the production and distribution of synthesizers. Furthermore, switching costs and interoperability requirements can affect partnerships between ecosystem participants. As part of a comprehensive value chain analysis, understanding these dynamics is crucial to navigating the ecosystem, particularly as regional differences may exist due to diverse regulatory environments and market demands.

Recent Industry Insights

The DNA and RNA Synthesizer industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between key players have led to the creation of innovative products and technologies, enhancing the industry's growth prospects. Notable mergers and acquisitions have also taken place, resulting in increased consolidation and competitiveness in the market. Furthermore, several product and technology launches have expanded the capabilities of DNA and RNA synthesizers, driving advancements in fields such as genetic engineering and gene editing. Regulatory changes have also played a crucial role in shaping the industry, with updates to guidelines and standards influencing the development and deployment of these technologies.

Additionally, there has been a shift in consumer and enterprise trends, with a growing demand for more efficient and cost-effective DNA and RNA synthesizers. This has led to increased funding rounds and expansions, enabling companies to invest in research and development and improve their product offerings. Overall, these developments are expected to continue driving growth and innovation in the DNA and RNA Synthesizer industry, with DNA and RNA Synthesizer industry trends likely to remain a key focus area for stakeholders in the coming years.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view of the DNA and RNA Synthesizer market. The market attractiveness is driven by increasing demand for personalized medicine and gene editing technologies. The competitive intensity is moderate, with key players investing in research and development to improve synthesizer efficiency and accuracy. The long-term outlook for the DNA and RNA Synthesizer market outlook is promising, with the global market expected to grow significantly over the next five years.

The innovation landscape is rapidly evolving, with advancements in artificial intelligence and machine learning expected to enhance synthesizer capabilities. However, the demand–supply balance may be affected by regulatory challenges and key risk factors, such as high development costs and intellectual property concerns. Despite these risks, the market is poised for significant growth, driven by increasing adoption of DNA and RNA synthesizers in biotechnology and pharmaceutical applications.

12 items

1. Executive Summary

2. DNA and RNA Synthesizer Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global DNA and RNA Synthesizer Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global DNA and RNA Synthesizer Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global DNA and RNA Synthesizer Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global DNA and RNA Synthesizer Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global DNA and RNA Synthesizer Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global DNA and RNA Synthesizer Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global DNA and RNA Synthesizer Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global DNA and RNA Synthesizer Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global DNA and RNA Synthesizer Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global DNA and RNA Synthesizer Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global DNA and RNA Synthesizer Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global DNA and RNA Synthesizer Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global DNA and RNA Synthesizer Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global DNA and RNA Synthesizer Market Competition by Key Manufacturers

9.1. Global DNA and RNA Synthesizer Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global DNA and RNA Synthesizer: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Thermo Fisher Scientific

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Applied Biosystems

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Beckman Coulter

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. GenScript Biotech

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. BioAutomation Corporation

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. K&A Labs GmbH

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Protein Technologies

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. CSBio

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. ACTGene

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Precision System Science

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. General Electric

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Polygen GmbH

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. GlobalSpec

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Biolytic Lab Performance

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Tekna Plasma Systems

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global DNA and RNA Synthesizer Market

Figure 4: Global DNA and RNA Synthesizer Market: Drivers

Figure 5: Global DNA and RNA Synthesizer Market: Challenges

Figure 6: Global DNA and RNA Synthesizer Market: Trends

Figure 7: Global DNA and RNA Synthesizer Market: Opportunity

Figure 8: Global DNA and RNA Synthesizer Market: Restraint

Figure 9: Global DNA and RNA Synthesizer Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global DNA and RNA Synthesizer Market Value (USD Million) By Region

Figure 19: Global DNA and RNA Synthesizer Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global DNA and RNA Synthesizer Market Value (USD Million) By Region

Figure 27: Global DNA and RNA Synthesizer Market Share (%) By: Regions (2032)

Figure 28: Global DNA and RNA Synthesizer Market Volume (K) By Region

Figure 29: Global DNA and RNA Synthesizer Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global DNA and RNA Synthesizer Market Value (USD Million) By Region

Figure 37: Global DNA and RNA Synthesizer Market Share (%) By: Regions (2032)

Figure 38: Global DNA and RNA Synthesizer Market Volume (K) By Region

Figure 39: Global DNA and RNA Synthesizer Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

125 items

Table 1: Market Segmentation Analysis

Table 2: Global DNA and RNA Synthesizer Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global DNA and RNA Synthesizer Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global DNA and RNA Synthesizer Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global DNA and RNA Synthesizer Market Value (USD Million) By Region

Table 14: Global DNA and RNA Synthesizer Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global DNA and RNA Synthesizer Market Volume (K) By Region

Table 31: Global DNA and RNA Synthesizer Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global DNA and RNA Synthesizer Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global DNA and RNA Synthesizer Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global DNA and RNA Synthesizer Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Thermo Fisher Scientific Basic Information And Sales Area

Table 52: Thermo Fisher Scientific. Products Portfolio

Table 53: Applied Biosystems Basic Information And Sales Area

Table 54: Applied Biosystems. Products Portfolio

Table 55: Beckman Coulter Basic Information And Sales Area

Table 56: Beckman Coulter. Products Portfolio

Table 57: GenScript Biotech Basic Information And Sales Area

Table 58: GenScript Biotech. Products Portfolio

Table 59: BioAutomation Corporation Basic Information And Sales Area

Table 60: BioAutomation Corporation. Products Portfolio

Table 61: K&A Labs GmbH Basic Information And Sales Area

Table 62: K&A Labs GmbH. Products Portfolio

Table 63: Protein Technologies Basic Information And Sales Area

Table 64: Protein Technologies. Products Portfolio

Table 65: CSBio Basic Information And Sales Area

Table 66: CSBio. Products Portfolio

Table 67: ACTGene Basic Information And Sales Area

Table 68: ACTGene. Products Portfolio

Table 69: Precision System Science Basic Information And Sales Area

Table 70: Precision System Science. Products Portfolio

Table 71: General Electric Basic Information And Sales Area

Table 72: General Electric. Products Portfolio

Table 73: Polygen GmbH Basic Information And Sales Area

Table 74: Polygen GmbH. Products Portfolio

Table 75: GlobalSpec Basic Information And Sales Area

Table 76: GlobalSpec. Products Portfolio

Table 77: Biolytic Lab Performance Basic Information And Sales Area

Table 78: Biolytic Lab Performance. Products Portfolio

Table 79: Tekna Plasma Systems Basic Information And Sales Area

Table 80: Tekna Plasma Systems. Products Portfolio

Table 81: Global Market Value (USD Million) (2025-2032) By Application

Table 82: Global Market Share (%) By Application (2032)

Table 83: Global Market Value (USD Million) (2025-2032) By Types

Table 84: Global Market Share (%) By Types (2032)

Table 85: Global Market Volume (K) (2025-2032) By Application

Table 86: Global Market Share (%) By Application (2032)

Table 87: Global Market Volume (K) (2025-2032) By Types

Table 88: Global Market Share (%) By Types (2032)

Table 89: Global DNA and RNA Synthesizer Market Value (USD Million) By Region

Table 90: Global DNA and RNA Synthesizer Market Share (%) By Region (2025-2032)

Table 91: North America Market Value (USD Million) (2025-2032) By Country

Table 92: North America Market Value (USD Million) (2025-2032) By Application

Table 93: North America Market Value (USD Million) (2025-2032) By Types

Table 94: Europe Market Value (USD Million) (2025-2032) By Country

Table 95: Europe Market Value (USD Million) (2025-2032) By Application

Table 96: Europe Market Value (USD Million) (2025-2032) By Types

Table 97: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 98: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 99: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 100: South America Market Value (USD Million) (2025-2032) By Country

Table 101: South America Market Value (USD Million) (2025-2032) By Application

Table 102: South America Market Value (USD Million) (2025-2032) By Types

Table 103: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 104: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 105: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 106: Global DNA and RNA Synthesizer Market Volume (K) By Region

Table 107: Global DNA and RNA Synthesizer Market Share (%) By Region (2025-2032)

Table 108: North America Market Volume (K) (2025-2032) By Country

Table 109: North America Market Volume (K) (2025-2032) By Application

Table 110: North America Market Volume (K) (2025-2032) By Types

Table 111: Europe Market Volume (K) (2025-2032) By Country

Table 112: Europe Market Volume (K) (2025-2032) By Application

Table 113: Europe Market Volume (K) (2025-2032) By Types

Table 114: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 115: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 116: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 117: South America Market Volume (K) (2025-2032) By Country

Table 118: South America Market Volume (K) (2025-2032) By Application

Table 119: South America Market Volume (K) (2025-2032) By Types

Table 120: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 121: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 122: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 123: Research Programs/Design For This Report

Table 124: Key Data Information From Secondary Sources

Table 125: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

DNA and RNA Synthesizer Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	510.00 million
Revenue forecast in 2033	889.46 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Fisher Scientific; Applied Biosystems; Beckman Coulter; GenScript Biotech; BioAutomation Corporation; K&A Labs GmbH; Protein Technologies; CSBio; ACTGene; Precision System Science; General Electric; Polygen GmbH; GlobalSpec; Biolytic Lab Performance; Tekna Plasma Systems
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

The high cost of DNA and RNA synthesizers and the limited availability of skilled professionals to operate these systems are restraining the growth of the DNA and RNA Synthesizer market

The stringent regulatory requirements and the need for compliance with various laws and regulations are also limiting the adoption of DNA and RNA synthesizers, thereby affecting the market size

Opportunities2 items

The expanding applications of DNA and RNA synthesizers in emerging markets and the growing demand for point-of-care diagnostics are also expected to drive the market's growth forecast

Challenges2 items

The complexity of DNA and RNA synthesis and the need for high-quality reagents and consumables are significant challenges faced by the DNA and RNA Synthesizer market

The intense competition among market players and the need for continuous innovation and product development are also major challenges that are affecting the market size and growth forecast

Market Segmentation

Loading chart…

DNA and RNA Synthesizer Segmentation Breakdown8 items

Application

Academic Institution

Pharmaceutical Company

Others

Types

Laboratory Grade

Industrial Grade

Large-scale Synthesis Grade

Regional Insights

Loading chart…

Competitive Landscape

Thermo Fisher Scientific: regional expansion

Applied Biosystems: innovation pipeline

Beckman Coulter: premium pricing

GenScript Biotech: local manufacturing

BioAutomation Corporation: OEM tie-ups

K&A Labs GmbH: vertical integration

Key DNA and RNA Synthesizer Companies15 items

Thermo Fisher Scientific

Applied Biosystems

Beckman Coulter

GenScript Biotech

BioAutomation Corporation

K&A Labs GmbH

Protein Technologies

CSBio

ACTGene

Precision System Science

General Electric

Polygen GmbH

GlobalSpec

Biolytic Lab Performance

Tekna Plasma Systems

Market Ecosystem

Raw material suppliers — provide essential components

Technology providers — develop synthesis technologies

OEMs/manufacturers — produce DNA and RNA synthesizers

System integrators — configure and install synthesizer systems

Distributors/channel partners — supply synthesizers to end users

Service providers — offer maintenance and support services

End users/buyers — utilize synthesizers for research and applications

Recent Industry Insights

Analyst Overview

Table of Contents